2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines
VA Ferraris, JR Brown, GJ Despotis… - The Annals of thoracic …, 2011 - Elsevier
BACKGROUND: Practice guidelines reflect published literature. Because of the ever
changing literature base, it is necessary to update and revise guideline recommendations …
changing literature base, it is necessary to update and revise guideline recommendations …
The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist
DC Warltier, JG Laffey, JF Boylan… - The Journal of the …, 2002 - pubs.asahq.org
THE purpose of this review is to evaluate recent developments in our understanding of the
inflammatory response to cardiac surgery. Scientific knowledge in this field is continually …
inflammatory response to cardiac surgery. Scientific knowledge in this field is continually …
The platelet in cardiopulmonary bypass
A Weerasinghe, KM Taylor - The Annals of thoracic surgery, 1998 - Elsevier
Platelets are the smallest of the blood cells and are known to be activated during
cardiopulmonary bypass. They play a role in many associated complications. Both …
cardiopulmonary bypass. They play a role in many associated complications. Both …
[HTML][HTML] Patient blood management during cardiac surgery: do we have enough evidence for clinical practice?
M Ranucci, S Aronson, W Dietrich, CM Dyke… - The Journal of Thoracic …, 2011 - jtcvs.org
Transfusion of allogeneic blood products during and after cardiac operations is common.
When the degree of anemia and the consequent decrease in oxygen delivery lead to organ …
When the degree of anemia and the consequent decrease in oxygen delivery lead to organ …
Platelet‐rich‐plasmapheresis for minimising peri‐operative allogeneic blood transfusion
PA Carless, FD Rubens, DM Anthony… - Cochrane Database …, 2011 - cochranelibrary.com
Background Concerns regarding the safety of transfused blood have generated
considerable enthusiasm for the use of technologies intended to reduce the use of …
considerable enthusiasm for the use of technologies intended to reduce the use of …
Intraoperative plateletpheresis and autologous platelet gel do not reduce chest tube drainage or allogeneic blood transfusion after reoperative coronary artery bypass …
P Wajon, J Gibson, R Calcroft, C Hughes… - Anesthesia & …, 2001 - journals.lww.com
IMPLICATIONS: This trial of plateletpheresis in reoperative coronary artery surgery was
performed to assess its effect on allogeneic blood product transfusion. Routine …
performed to assess its effect on allogeneic blood product transfusion. Routine …
Platelet-rich plasma sequestration, with therapeutic platelet yields, reduces allogeneic transfusion in complex cardiac surgery
EP Stover, LC Siegel, PA Hood… - Anesthesia & …, 2000 - journals.lww.com
Platelet dysfunction is the most common cause of nonsurgical bleeding after
cardiopulmonary bypass (CPB). We hypothesized that reinfusion of a therapeutic quantity of …
cardiopulmonary bypass (CPB). We hypothesized that reinfusion of a therapeutic quantity of …
[HTML][HTML] Platelet-rich plasmapheresis in cardiac surgery: a meta-analysis of the effect on transfusion requirements
Objective: Our purpose was to determine whether intraoperative platelet-rich
plasmapheresis in cardiac surgery is effective in reducing the proportion of patients exposed …
plasmapheresis in cardiac surgery is effective in reducing the proportion of patients exposed …
Autologous platelet-rich plasmapheresis in cardiovascular surgery: a narrative review
SJ Bai, B Zeng, L Zhang, Z Huang - Journal of cardiothoracic and vascular …, 2020 - Elsevier
Perioperative coagulopathy and bleeding are common complications in cardiovascular
surgery with cardiopulmonary bypass and result in an increased rate of allogeneic blood …
surgery with cardiopulmonary bypass and result in an increased rate of allogeneic blood …
A review of randomized controlled trials using therapeutic apheresis
N Shehata, C Kouroukis, JG Kelton - Transfusion medicine reviews, 2002 - Elsevier
Apheresis has developed into a common therapeutic modality. The evidence for the clinical
benefit of apheresis, however, is generally from uncontrolled and nonrandomized trials …
benefit of apheresis, however, is generally from uncontrolled and nonrandomized trials …